相关实验视频

Updated: Jun 3, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

形态如何塑造肺部侵袭性状细胞癌的生存率

Angela-Ștefania Marghescu^1,2, Silviu Vlăsceanu^3,4, Mădălina Preda^5,6

¹Pathological Anatomy Discipline, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.

Diagnostics (Basel, Switzerland)

|October 25, 2024

概括

预后因素如非角质化瘤,晚期,单细胞入侵和高线粒体指数显著影响肺状细胞癌 (SQCC) 的存活率. 详细的组织病理学对于准确的风险分层和治疗指导至关重要.

科学领域:

在瘤学瘤学.
病理学病理学病理学
手术瘤学手术瘤学

背景情况:

状细胞癌 (SQCC) 是一种常见的人类恶性瘤,对肺癌病例有重大影响.
准确的预后因素识别对于有效的风险分层和肺SQCC患者管理至关重要.

研究的目的:

确定和验证影响可手术肺状细胞癌患者整体存活期的关键组织病理预后因素.
加强风险分层,指导肺SQCC的治疗策略.

主要方法:

对99例可手术的肺部SQCC病例的回顾性分析,这些病例在三级中心接受治疗.
包括详细的组织病理学变量,pTNM分期和整体生存数据.
应用卡普兰-梅尔生存分析和考克斯回归模型用于预后因素识别.

主要成果:

平均存活时间为36个月,死亡率为65.65%.
显著的预后因素包括角质化,组织学等级,瘤大小/阶段,膜入侵,细胞排列,瘤芽,STAS和线粒指数.
非质化瘤,晚期PT阶段,单细胞侵袭和高线粒体指数是较差结果的独立预测因素.

结论:

详细的组织病理学评估对于肺SQCC预后至关重要.
非化组织学,晚期PT阶段,单细胞入侵和高线粒体指数与死亡率的增加有关.
将这些因素纳入全面的分级系统可以提高预后准确性和治疗规划.

关键词:

评分分级的评分分级.肺肺肺肺肺肺肺肺肺形态学因素形态学因素预后预测预测的预测.风险分层的风险分层.状细胞癌的癌症.幸存率幸存率生存率

更多相关视频

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

相关概念视频

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...